These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7818005)

  • 1. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss.
    Sugerman HJ; Brewer WH; Shiffman ML; Brolin RE; Fobi MA; Linner JH; MacDonald KG; MacGregor AM; Martin LF; Oram-Smith JC
    Am J Surg; 1995 Jan; 169(1):91-6; discussion 96-7. PubMed ID: 7818005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
    Wudel LJ; Wright JK; Debelak JP; Allos TM; Shyr Y; Chapman WC
    J Surg Res; 2002 Jan; 102(1):50-6. PubMed ID: 11792152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery (UPGRADE): a multicentre, double-blind, randomised, placebo-controlled superiority trial.
    Haal S; Guman MSS; Boerlage TCC; Acherman YIZ; de Brauw LM; Bruin S; de Castro SMM; van Hooft JE; van de Laar AWJM; Moes DE; Schouten M; Schouten R; van Soest EJ; van Veen RN; de Vries CEE; Fockens P; Dijkgraaf MGW; Gerdes VEA; Voermans RP
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):993-1001. PubMed ID: 34715031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial.
    Miller K; Hell E; Lang B; Lengauer E
    Ann Surg; 2003 Nov; 238(5):697-702. PubMed ID: 14578732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the cost savings resulting from the use of ursodiol for the prevention of gallstones in obese patients undergoing rapid weight reduction.
    Shoheiber O; Biskupiak JE; Nash DB
    Int J Obes Relat Metab Disord; 1997 Nov; 21(11):1038-45. PubMed ID: 9368828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative ultrasound and prophylactic ursodiol for gallstone prevention following laparoscopic gastric bypass.
    Scott DJ; Villegas L; Sims TL; Hamilton EC; Provost DA; Jones DB
    Surg Endosc; 2003 Nov; 17(11):1796-802. PubMed ID: 12958683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
    Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
    BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man.
    Marks JW; Stein T; Schoenfield LJ
    Dig Dis Sci; 1994 Sep; 39(9):1981-4. PubMed ID: 8082507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ursodeoxycholic acid therapy on gallstone formation in the morbidly obese during rapid weight loss.
    Worobetz LJ; Inglis FG; Shaffer EA
    Am J Gastroenterol; 1993 Oct; 88(10):1705-10. PubMed ID: 8213711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program.
    Shiffman ML; Kaplan GD; Brinkman-Kaplan V; Vickers FF
    Ann Intern Med; 1995 Jun; 122(12):899-905. PubMed ID: 7755224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of symptomatic gallstones after gastric bypass: is prophylactic treatment really necessary?
    Caruana JA; McCabe MN; Smith AD; Camara DS; Mercer MA; Gillespie JA
    Surg Obes Relat Dis; 2005; 1(6):564-7; discussion 567-8. PubMed ID: 16925292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity.
    Shiffman ML; Sugerman HJ; Kellum JM; Brewer WH; Moore EW
    Am J Gastroenterol; 1991 Aug; 86(8):1000-5. PubMed ID: 1858735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodiol Prescriptions Following Bariatric Surgery: National Prescribing Trends and Outcomes.
    Coogan AC; Williams MD; Krishnan V; Skertich NJ; Becerra AZ; Sarran M; Schimpke S; Torquati A; Omotosho P
    Obes Surg; 2023 Aug; 33(8):2361-2367. PubMed ID: 37392353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Ursodeoxycholic Acid for the Prevention of Gallstone Formation After Gastrectomy in Patients With Gastric Cancer: The PEGASUS-D Randomized Clinical Trial.
    Lee SH; Jang DK; Yoo MW; Hwang SH; Ryu SY; Kwon OK; Hur H; Man Yoon H; Eom BW; Ahn HS; Son T; Song KY; Lee HH; Choi MG; An JY; Lee SI; Lee KH; Ahn S; Park YS; Park DJ;
    JAMA Surg; 2020 Aug; 155(8):703-711. PubMed ID: 32584935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial).
    Haal S; Guman MSS; de Brauw LM; van Veen RN; Schouten R; Fockens P; Gerdes VEA; Dijkgraaf MGW; Voermans RP
    Trials; 2020 Jul; 21(1):676. PubMed ID: 32703246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contributions of obesity and weight loss to gallstone disease.
    Everhart JE
    Ann Intern Med; 1993 Nov; 119(10):1029-35. PubMed ID: 8214980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy.
    Adams LB; Chang C; Pope J; Kim Y; Liu P; Yates A
    Obes Surg; 2016 May; 26(5):990-4. PubMed ID: 26342481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.
    Essell JH; Schroeder MT; Harman GS; Halvorson R; Lew V; Callander N; Snyder M; Lewis SK; Allerton JP; Thompson JM
    Ann Intern Med; 1998 Jun; 128(12 Pt 1):975-81. PubMed ID: 9625683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of Ursolit for gallstone prophylaxis following bariatric surgery: a randomized-controlled trial.
    Sakran N; Dar R; Assalia A; Neeman Z; Farraj M; Sherf-Dagan S; Gralnek IM; Hazzan R; Mokary SE; Nevo-Aboody H; Dola T; Kaplan U; Hershko D
    Updates Surg; 2020 Dec; 72(4):1125-1133. PubMed ID: 32666477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Ursodeoxycholic Acid (UDCA) in Cholelithiasis Management After One Anastomosis Gastric Bypass (OAGB) for Morbid Obesity: Results of a Monocentric Randomized Controlled Trial.
    Pizza F; D'Antonio D; Lucido FS; Tolone S; Del Genio G; Dell'Isola C; Docimo L; Gambardella C
    Obes Surg; 2020 Nov; 30(11):4315-4324. PubMed ID: 32583297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.